home / stock / clvs / clvs quote
Last: | $0.0812 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0812 |
High: | $0 |
Low: | $0 |
Volume: | 1,639 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0812 | $0 | $0.0812 | $0 | $0 | 1,639 | 01-03-2023 |
$0.0812 | $0 | $0.0812 | $0 | $0 | 218 | 12-29-2022 |
$0.0812 | $0.0808 | $0.0812 | $0.0977 | $0.0766 | 24,516,461 | 12-20-2022 |
$0.086 | $0.08 | $0.086 | $0.092 | $0.077 | 19,780,678 | 12-19-2022 |
$0.08 | $0.0952 | $0.08 | $0.1099 | $0.076 | 22,992,778 | 12-16-2022 |
$0.0982 | $0.1078 | $0.0982 | $0.1079 | $0.092 | 15,671,146 | 12-15-2022 |
$0.1055 | $0.14 | $0.1055 | $0.1439 | $0.1026 | 24,439,580 | 12-14-2022 |
$0.1332 | $0.1845 | $0.1332 | $0.1965 | $0.1251 | 18,726,421 | 12-13-2022 |
$0.2015 | $0.206 | $0.2015 | $0.275 | $0.172 | 28,327,640 | 12-12-2022 |
$0.2002 | $0.222 | $0.2002 | $0.229 | $0.2002 | 2,435,764 | 12-09-2022 |
$0.2223 | $0.2155 | $0.2223 | $0.2389 | $0.2019 | 4,019,124 | 12-08-2022 |
$0.2234 | $0.24 | $0.2234 | $0.25 | $0.223 | 2,693,680 | 12-07-2022 |
$0.252 | $0.28 | $0.252 | $0.291 | $0.237 | 4,719,040 | 12-06-2022 |
$0.2915 | $0.31 | $0.2915 | $0.324 | $0.29 | 4,457,083 | 12-05-2022 |
$0.3438 | $0.35 | $0.3438 | $0.3599 | $0.333 | 2,682,279 | 12-02-2022 |
$0.36 | $0.3298 | $0.36 | $0.3772 | $0.3203 | 2,541,244 | 12-01-2022 |
$0.33 | $0.32 | $0.33 | $0.3499 | $0.3169 | 1,698,950 | 11-30-2022 |
$0.3139 | $0.34 | $0.3139 | $0.3428 | $0.3101 | 1,998,737 | 11-29-2022 |
$0.3399 | $0.3359 | $0.3399 | $0.3552 | $0.3234 | 2,075,150 | 11-28-2022 |
$0.346 | $0.3322 | $0.346 | $0.35 | $0.3207 | 926,093 | 11-25-2022 |
News, Short Squeeze, Breakout and More Instantly...
Clovis Oncology Inc. Company Name:
CLVS Stock Symbol:
NASDAQ Market:
100.0% G/L:
$0.0812 Last:
1,639 Volume:
$0 Open:
$0.0812 Close:
Clovis Oncology Inc. Website:
Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., E...